p53 suppresses neuroendocrine carcinoma progression by inhibiting cell growth associated with mTOR pathway activation

被引:0
|
作者
Akeno, Nagako [1 ]
Nikenheiser-Brokamp, Kathryn A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
关键词
D O I
10.1158/1538-7445.AM2011-2893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2893
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway
    Gao, Lvfen
    Chen, Ming
    Ouyang, Yuan
    Li, Ruobin
    Zhang, Xian
    Gao, Xuesong
    Lin, Shaoqiang
    Wang, Xiaoyu
    LIFE SCIENCES, 2018, 202 : 188 - 194
  • [22] ALTERATIONS OF THE P53 GENE ARE ASSOCIATED WITH THE PROGRESSION OF A HUMAN PROSTATE CARCINOMA
    EFFERT, PJ
    NEUBAUER, A
    WALTHER, PJ
    LIU, ET
    JOURNAL OF UROLOGY, 1992, 147 (03): : 789 - 793
  • [23] DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity
    Danrui Cui
    Xiaoqing Dai
    Longyuan Gong
    Xiaoyu Chen
    Linchen Wang
    Xiufang Xiong
    Yongchao Zhao
    Cell Death & Disease, 11
  • [24] DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity
    Cui, Danrui
    Dai, Xiaoqing
    Gong, Longyuan
    Chen, Xiaoyu
    Wang, Linchen
    Xiong, Xiufang
    Zhao, Yongchao
    CELL DEATH & DISEASE, 2020, 11 (11)
  • [25] Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma
    Bo Kong
    Tao Cheng
    Chengjia Qian
    Weiwei Wu
    Katja Steiger
    Jing Cao
    Anna Melissa Schlitter
    Ivonne Regel
    Susanne Raulefs
    Helmut Friess
    Mert Erkan
    Irene Esposito
    Jörg Kleeff
    Christoph W. Michalski
    Molecular Cancer, 14
  • [26] Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma
    Kong, Bo
    Cheng, Tao
    Qian, Chengjia
    Wu, Weiwei
    Steiger, Katja
    Cao, Jing
    Schlitter, Anna Melissa
    Regel, Ivonne
    Raulefs, Susanne
    Friess, Helmut
    Erkan, Mert
    Esposito, Irene
    Kleeff, Joerg
    Michalski, Christoph W.
    MOLECULAR CANCER, 2015, 14
  • [27] Inhibition of Retinoblastoma Cell Growth by CEP1347 Through Activation of the P53 Pathway
    Togashi, Keita
    Okada, Masashi
    Suzuki, Shuhei
    Sanomachi, Tomomi
    Seino, Shizuka
    Yamamoto, Masahiro
    Yamashita, Hidetoshi
    Kitanaka, Chifumi
    ANTICANCER RESEARCH, 2020, 40 (09) : 4961 - 4968
  • [28] Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation
    Zhang, Xiang
    Cheng, Dezhi
    Liu, Yu
    Wu, Yuanbo
    He, Zhifeng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 5333 - 5341
  • [29] Lentinan suppresses the progression of neuroblastoma by inhibiting FOS-mediated transcription activation of VRK1 to stabilize p53 protein
    Zhao, Zhang
    Li, Jiahao
    Zhang, Liyu
    Wang, Jiayu
    Li, Dian
    Zheng, Manna
    Ye, Zijie
    Yang, Tianyou
    Zou, Yan
    Pan, Jing
    Xu, Hui
    Zeng, Huijuan
    Hu, Chao
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [30] AKT-mTOR pathway mediates mutant p53 gain-of-function by inhibiting autophagy
    Guo, Xiaolan
    Zhao, Liyan
    Xiong, Hua
    Auringer, Kyle
    Wang, Lei
    Deng, Yibin
    CANCER RESEARCH, 2012, 72